Sanofi joins ITU in the Be He@lthy, Be Mobile initiative
bringing mobile health solutions to people with diabetes

Be He@lthy, Be Mobile is a ground breaking initiative led by the International Telecommunication Union (ITU) in collaboration with the World Health Organization (WHO) which focuses on the use of mobile technologies to improve the prevention and treatment of non-communicable diseases (NCDs) – with diabetes as a priority – as well as related concomitant diseases.

NCDs (including cancer, stroke, heart disease, lung diseases and diabetes) are the leading cause of death worldwide, while prevention and treatment requirements dominate the allocation of healthcare expenditure.1 Newly published data from the International Diabetes Federation highlights that the impact of diabetes could bankrupt some national healthcare systems.2

Today, the rapid rise of mobile device use in developing countries and the positive role of mobile technology in health promotion have the potential to address many health issues associated with the prevalence of NCDs, via investing in technologies which already sit in their pockets to bring direct, accessible and affordable support to people. Aligned to the WHO Global Action Plan for the prevention and control of NCDs 25*25, the Be He@lthy, Be Mobile initiative harnesses mobile technologies to help reduce the social and economic burden that NCDs generate by creating a continuum of care in an individual’s life from prevention advice to disease support.

Becoming the strategic partner in ITU’s mDiabetes initiative is a natural step in Sanofi’s pledge to take a leading role in delivering meaningful advancements for people living with diabetes”, explained Pascale Witz, Executive Vice President, Sanofi Global Divisions & Strategic Development. “Together, with governments, policy makers and other private companies at the forefront of global health and innovation, we aim to support the harnessing of mobile and other technologies to enable learning and positive action among people who are affected by diabetes in our increasingly connected world”.

Working with other partners at the forefront of health innovation, Sanofi has developed an mDiabetes toolkit and educational guidelines outlining best-practices for health care professionals (HCPs) for diabetes management and care. Together with ITU, the company will also work with the existing center of excellence in Senegal, the pilot country, to improve training guidelines for HCPs and build capacity.

Sanofi’s global reach and diabetes knowledge will help expand the excellent pilot work undertaken in Senegal”, added Pierre Chancel, Senior Vice President, Sanofi Global Diabetes. “Through Sanofi’s support the initiative will employ successful mobile strategies for people with diabetes and their caregivers and provide access to training for health workers in additional countries around the world, furthering our aim of bringing about far-reaching improvements in diabetes management, treatment and care”.

The partnership of Sanofi in Be He@lthy, Be Mobile demonstrates that investing in mTechnology can address society-wide health issues by giving individuals the means to foster behavioral change via health promotion and empower them to manage their own condition. The strengths of a multi-sector partnership structure that brings together the private sector, academia and civil society – acknowledges that the resources of government and philanthropy alone are insufficient to address the world’s biggest health challenges.


1. WHO. Noncommunicable diseases. Fact sheet no. 355: World Health Organisation;. Available from: Accessed at: 24 February 2015.        
2.  IDF Atlas 6th Edn. 2014 update. Brussels, Belgium: International Diabetes Federation, 2014.  Accessed at: 24 February 2015.